Altimmune, Inc.Long
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND f
ALT: Altimmune, Inc
2022-01-31 07:00:00
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
2022-01-31 07:00:00
Altimmune Announces FDA Clearance of Pemvidutide (ALT-801) IND for Obesity
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.